SIRONA 2 Trial Heart Failure NYHA Class III | MicrobiomeTrials← Back to trialsNCT04012944
SIRONA 2 Trial Heart Failure NYHA Class III
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2019-06-26Est. Completion: 2021-10-30
Enrollment target: 81 participants Locations- Cardivascular Center OLV Aalst, Aalst, Belgium
- Ziekenhuis- Oost Limburg, Genk, Belgium
- Uniklinik Köln, Klinik III für Innere Medizin Herzzentrum der Universität zu Köln, Cologne, Germany
- Universitätsklinikum Giessen und Marburg GmbH, Standort Giessen Medizinische Klinik I, Abteilung Kardiologie und Angiologie, Giessen, Germany
- Klinik für Kardiologie und Angiologie/ Studienambulanz Medizinische Hochschule Hannover (MHH), Hanover, Germany
- Mater Misericordiae University Hospital, Dublin, Ireland
- University Hospital Galway, Dublin, Ireland
Other microbiome trials you might be interested in
Ventricular ArrythmiaNon-ischemic CardiomyopathyArrhythmogenic Inflammatory Cardiomyopathy
Ventricular tachycardia (VT, a potentially fatal condition where the ventricle of the heart beats rapidly) superimposed …
Phoenix, United StatesCompleted Oct 2026
Mitral Valve Regurgitation
The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter He…
Los Angeles, United StatesCompleted Jan 6, 2020